X-D Wu1, X Tian2, M-M Liu3, L Wu4, S Zhao2, L Zhao5. 1. First College of Clinical Medicine, Chongqing Medical University, Chongqing, China. 2. Graduate College of Tianjin University of Traditional Chinese Medicine, Tianjin, China. 3. Department of Clinical Medicine, Shandong University, Jinan, China. 4. Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, USA. 5. Department of Graduate School, Guangxi Medical University, Nanning, China.
Abstract
BACKGROUND: Previous studies comparing early laparoscopic cholecystectomy (ELC) with delayed laparoscopic cholecystectomy (DLC) for acute cholecystitis were incomplete. A meta-analysis was undertaken to compare the cost-effectiveness, quality of life, safety and effectiveness of ELC versus DLC. METHODS: PubMed, Embase, the Cochrane Library and Web of Science were searched for randomized clinical trials (RCTs) that compared ELC (performed within 7 days of symptom onset) with DLC (undertaken at least 1 week after symptoms had subsided) for acute cholecystitis. RESULTS: Sixteen studies reporting on 15 RCTs comprising 1625 patients were included. Compared with DLC, ELC was associated with lower hospital costs, fewer work days lost (mean difference (MD) -11·07 (95 per cent c.i. -16·21 to -5·94) days; P < 0·001), higher patient satisfaction and quality of life, lower risk of wound infection (relative risk 0·65, 95 per cent c.i. 0·47 to 0·91; P = 0·01) and shorter hospital stay (MD -3·38 (-4·23 to -2·52) days; P < 0·001), but a longer duration of operation (MD 11·12 (4·57 to 17·67) min; P < 0·001). There were no significant differences between the two groups in mortality, bile duct injury, bile leakage, conversion to open cholecystectomy or overall complications. CONCLUSION: For patients with acute cholecystitis, ELC appears as safe and effective as DLC. ELC might be associated with lower hospital costs, fewer work days lost, and greater patient satisfaction.
BACKGROUND: Previous studies comparing early laparoscopic cholecystectomy (ELC) with delayed laparoscopic cholecystectomy (DLC) for acute cholecystitis were incomplete. A meta-analysis was undertaken to compare the cost-effectiveness, quality of life, safety and effectiveness of ELC versus DLC. METHODS: PubMed, Embase, the Cochrane Library and Web of Science were searched for randomized clinical trials (RCTs) that compared ELC (performed within 7 days of symptom onset) with DLC (undertaken at least 1 week after symptoms had subsided) for acute cholecystitis. RESULTS: Sixteen studies reporting on 15 RCTs comprising 1625 patients were included. Compared with DLC, ELC was associated with lower hospital costs, fewer work days lost (mean difference (MD) -11·07 (95 per cent c.i. -16·21 to -5·94) days; P < 0·001), higher patient satisfaction and quality of life, lower risk of wound infection (relative risk 0·65, 95 per cent c.i. 0·47 to 0·91; P = 0·01) and shorter hospital stay (MD -3·38 (-4·23 to -2·52) days; P < 0·001), but a longer duration of operation (MD 11·12 (4·57 to 17·67) min; P < 0·001). There were no significant differences between the two groups in mortality, bile duct injury, bile leakage, conversion to open cholecystectomy or overall complications. CONCLUSION: For patients with acute cholecystitis, ELC appears as safe and effective as DLC. ELC might be associated with lower hospital costs, fewer work days lost, and greater patient satisfaction.
Authors: A C Murray; S Markar; H Mackenzie; O Baser; T Wiggins; A Askari; G Hanna; O Faiz; E Mayer; C Bicknell; A Darzi; R P Kiran Journal: Surg Endosc Date: 2018-01-08 Impact factor: 4.584
Authors: M Boules; I N Haskins; M Farias-Kovac; A D Guerron; D Schechtman; M Samotowka; C P O'Rourke; G McLennan; R M Walsh; G Morris-Stiff Journal: Surg Endosc Date: 2016-08-12 Impact factor: 4.584
Authors: Julia F Kohn; Alexander Trenk; Kristine Kuchta; Brittany Lapin; Woody Denham; John G Linn; Stephen Haggerty; Ray Joehl; Michael B Ujiki Journal: Surg Endosc Date: 2017-08-24 Impact factor: 4.584
Authors: Jarrod K H Tan; Joel C I Goh; Janice W L Lim; Iyer G Shridhar; Krishnakumar Madhavan; Alfred W C Kow Journal: J Gastrointest Surg Date: 2017-02-27 Impact factor: 3.452
Authors: Jonathan B Yuval; Ido Mizrahi; Haggi Mazeh; Daniel J Weiss; Gidon Almogy; Miklosh Bala; Eran Kuchuk; Baha Siam; Natalia Simanovsky; Ahmed Eid; Alon J Pikarsky Journal: World J Surg Date: 2017-07 Impact factor: 3.352
Authors: Philippe Paci; Nancy E Mayo; Pepa A Kaneva; Julio F Fiore; Gerald M Fried; Liane S Feldman Journal: Surg Endosc Date: 2017-10-19 Impact factor: 4.584